---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-007032"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T12:18:11.294379+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q4/FY2023 revenue up 7.7% to $3.2B, net loss $678.9M from goodwill impairment; guides 2024

## Summary
- FY2023 net revenue $3,200.2M (+7.7% YoY); net loss $678.9M vs $69.3M profit, driven by $830.8M pretax goodwill impairment.
- Q4 net revenue $858.2M (+10%); adjusted EBITDA $204.6M (+40.2%).
- FY2023 adjusted EBITDA $670.8M (+13%); free cash flow $143.2M vs ($17.6M) prior year.
- Initial FY2024 guidance: net revenue $3.25-3.35B, adjusted EBITDA $650-710M, free cash flow $150-180M.
- Leverage ratio improved to 3.16x from 3.69x year-end 2022.

## SEC filing metadata
- accession: 0001628280-24-007032
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828024007032/0001628280-24-007032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828024007032/ahco-20240227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-007032
- JSON: https://secwatch.observer/filing/0001628280-24-007032.json
- Plain text: https://secwatch.observer/filing/0001628280-24-007032.txt

## Key facts
- Earnings Releases
  AdaptHealth Corp. reported fourth quarter and fiscal year ended December 31, 2023 results: revenue Net revenue was $3,200.2 million, net income Net loss attributable to AdaptHealth Corp. was $678.9 million. Guidance initiated.
  - Period: fourth quarter and fiscal year ended December 31, 2023
  - Revenue: Net revenue was $3,200.2 million
  - Net income: Net loss attributable to AdaptHealth Corp. was $678.9 million
  - Guidance: initiated
  - Result: reported results
  source text: announced today financial results for the fourth quarter and fiscal year ended December 31, 2023. Full Year 2023 Results and Highlights All comparisons are to the year ended December 31, 2022 unless otherwise stated. • Net revenue was $3,200.2 million compared to $2,970.6 million, an increase of 7.7% driven by non-acquired growth of 7.3%. • Net loss attributable to AdaptHealth Corp. was $678.9 million compared to net income of $69.3 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725255/000162828024007032/0001628280-24-007032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.